U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Nelson HD, Morris CD, Kraemer DF, et al. Osteoporosis in Postmenopausal Women: Diagnosis and Monitoring. Rockville (MD): Agency for Healthcare Research and Quality (US); 2001 Nov. (Evidence Reports/Technology Assessments, No. 28.)

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Osteoporosis in Postmenopausal Women: Diagnosis and Monitoring

Osteoporosis in Postmenopausal Women: Diagnosis and Monitoring.

Show details

References

1.
Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med. 1991;90:107–10. [PubMed: 1986575]
2.
Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med. 1993;94:646–50. [PubMed: 8506892]
3.
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. Geneva: World Health Organization; 1994. [PubMed: 7941614]
4.
Kanis JA Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report Osteoporos Int 19944(6):368–81. [PubMed: 7696835]
5.
Sandor T, Felsenberg D, Brown E Comments on the hypotheses underlying fracture risk assessment in osteoporosis as proposed by the World Health Organization Calcif Tissue Int 199964(3):267–70. [PubMed: 10024389]
6.
Marcus R., Holloway L, Wells B, et al The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial J Bone Miner Res 199914(9):1583–95. [PubMed: 10469288]
7.
Wasnich RD Consensus and the T-score fallacy Clin Rheumatol 199716(4):337–9. [PubMed: 9259244]
8.
National Osteoporosis Foundation Osteoporosis: review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis Osteoporos Int 19988Suppl 4:S7–80. [PubMed: 10197173]
9.
Black DM, Palermo L, Genant HK, et al Four reasons to avoid the use of BMD T-scores in treatment decisions for osteoporosis J Bone Miner Res 199611(Suppl 1):–.
10.
Faulkner KG, von Stetten E, Miller P Discordance in patient classification using T-scores J Clin Densitomet 19992(3):343–50. [PubMed: 10548828]
11.
Marcus R Clinical review 76: the nature of osteoporosis J Clin Endocrinol Metab 199681(1):1–5. [PubMed: 8550734]
12.
Abbott TA 3rd, Mucha L, Manfredonia D, et al Efficient patient identification strategies for women with osteoporosis J Clin Densitomet 19992(3):223–30. [PubMed: 10548818]
13.
Kanis JA, Gluer CC An update on the diagnosis and assessment of osteoporosis with densitometry Osteoporos Int 200011(3):192–202. [PubMed: 10824234]
14.
Looker AC, Orwoll ES, Johnston CC Jr., et al Prevalence of low femoral bone density in older US adults from NHANES III J Bone Miner Res 199712(11):1761–8. [PubMed: 9383679]
15.
Looker AC, Wahner LW, Dunn WL, et al Updated data on proximal femur bone mineral levels of US adults Osteoporos Int 19988(5):468–89. [PubMed: 9850356]
16.
Melton LJ 3rd How many women have osteoporosis now? J Bone Miner Res 199510(2):175–7. [PubMed: 7754796]
17.
Heaney RP Bone mass, bone loss, and osteoporosis prophylaxis Ann Intern Med 1998128(4):313–4. [PubMed: 9471936]
18.
Melton LJ 3rd, Atkinson EJ, O'Connor MK, et al Bone density and fracture risk in men J Bone Miner Res 199813(12):1915–23. [PubMed: 9844110]
19.
Farmer ME, White LR, Brody JA, et al Race and sex differences in hip fracture incidence Am J Public Health 198474(12):1374–80. [PMC free article: PMC1652702] [PubMed: 6507690]
20.
Melton LJ 3rd, Amadio PC, Crowson CS, et al Long-term trends in the incidence of distal forearm fractures. Osteoporos Int. 1998;8:341–8. [PubMed: 10024904]
21.
Melton LJ 3rd, Kan SH, Frye MA, et al Epidemiology of vertebral fractures in women Am J Epidemiol 1989129(5):1000–11. [PubMed: 2784934]
22.
Melton LJ 3rd Epidemiology of spinal osteoporosis Spine 199722(24 Suppl):2S–11S. [PubMed: 9431638]
23.
Jacobsen SJ, Cooper C, Gottlieb MS, et al Hospitalization with vertebral fracture among the aged: a national population-based study,1986-1989 Epidemiology 19923(6):515–8. [PubMed: 1420517]
24.
Gold DT The clinical impact of vertebral fractures: quality of life in women with osteoporosis Bone 199618(Suppl 3):S185–S9. [PubMed: 8777086]
25.
Nevitt MC, Ettinger B, Black DM, et al The association of radiographically detected vertebral fractures with back pain and function: a prospective study Ann Intern Med 1998128(10):793–800. [PubMed: 9599190]
26.
Chrischilles EA, Butler CD, Davis CS, et al A model of lifetime osteoporosis impact Arch Intern Med 1991151(10):2026–32. [PubMed: 1929691]
27.
Cook DJ, Guyatt GH, Adachi JD, et al Quality of life issues in women with vertebral fractures due to osteoporosis Arthritis Rheum 199336(6):750–6. [PubMed: 8507215]
28.
Chander JM, Martin AR, Girman C, et al Reliability of an osteoporosis-targeted quality of life survey instrument for use in the community: OPT-QoL. Osteoporos Int. 1998;8:127–35. [PubMed: 9666935]
29.
Lyles KW, Gold DW, Shipp KM, et al Association of osteoporotic vertebral fractures with impaired functional status. Am J Med. 1993;94:595–601. [PubMed: 8506884]
30.
Ray NF, Chan JK, Thamer M, et al Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation J Bone Miner Res 199712(1):24–35. [PubMed: 9240722]
31.
Rosner AJ, Grima DT, Torrance GW, et al Cost effectiveness of multi-therapy treatment strategies in the prevention of vertebral fractures in postmenopausal women with osteoporosis Pharmacoeconomics 199814(5):559–73. [PubMed: 10344918]
32.
Abbott TA, Lawrence BJ, Wallach S Osteoporosis: the need for comprehensive treatment guidelines Clin Ther 199618(1):127–49. [PubMed: 8851459]
33.
Blake GM, Gluer CC, Fogelman I Bone densitometry: current status and future prospects. Spec No:S177-86. Br J Radiol. 1997;70 [PubMed: 9534732]
34.
Blake GM, Fogelman I Applications of bone densitometry for osteoporosis Endocrinol Metab Clin North Am 199827(2):267–88. [PubMed: 9669138]
35.
Genant HK, Engelke K, Fuerst T, et al Noninvasive assessment of bone mineral and structure: state of the art J Bone Miner Res 199611(6):707–30. [PubMed: 8725168]
36.
Jergas M, Genant HK Spinal and femoral DXA for the assessment of spinal osteoporosis Calcif Tissue Int 199761(5):351–7. [PubMed: 9351874]
37.
Cameron JR, Sorenson J Measurement of bone mineral in vivo: an improved method. Science. 1963;142:230–2. [PubMed: 14057368]
38.
Langton CM, Palmer SB, Porter RW The measurement of broadband ultrasonic attenuation in cancellous bone Eng Med 198413(2):89–91. [PubMed: 6540216]
39.
Lochmuller EM, Eckstein F, Kaiser D, et al Prediction of vertebral failure loads from spinal and femoral dual-energy X-ray absorptiometry, and calcaneal ultrasound: an in situ analysis with intact soft tissues Bone 199823(5):417–24. [PubMed: 9823447]
40.
Bouxsein ML, Radloff SE Quantitative ultrasound of the calcaneus reflects the mechanical properties of calcaneal trabecular bone J Bone Miner Res 199712(5):839–46. [PubMed: 9144351]
41.
Bouxsein ML, Coan BS, Lee SC Prediction of the strength of the elderly proximal femur by bone mineral density and quantitative ultrasound measurements of the heel and tibia Bone 199925(1):49–54. [PubMed: 10423021]
42.
Lochmuller EM, Zeller JB, Kaiser D, et al Correlation of femoral and lumbar DXA and calcaneal ultrasound, measured in situ with intact soft tissues, with the in vitro failure loads of the proximal femur Osteoporos Int 19988(6):591–8. [PubMed: 10326066]
43.
Nicholson PHF, Muller R, Lowet G, et al Do quantitative ultrasound measurements reflect structure independently of density in human vertebral cancellous bone? Bone 199823(5):425–31. [PubMed: 9823448]
44.
Cummings SR, Black DM, Nevitt MC, et al Bone density at various sites for prediction of hip fractures. Lancet. 1993;341:72–5. [PubMed: 8093403]
45.
Huang C, Ross PD, Yates AJ, et al Prediction of fracture risk by radiographic absorptiometry and quantitative ultrasound: a prospective study Calcif Tissue Int 199863(5):380–4. [PubMed: 9799821]
46.
Langton CM, Ballard PA, Bennett DK, et al A comparison of the sensitivity and specificity of calcaneal ultrasound measurements with clinical criteria for bone densitometry (DEXA) referral Clin Rheumatol 199716(1):117–8. [PubMed: 9132320]
47.
Richmond BJ Enthusiasm for ultrasound for osteoporosis screening is premature Cleve Clin J Med 199865(8):403–4. [PubMed: 9769560]
48.
Cummings SR Prevention of hip fractures in older women: a population-based perspective Osteoporos Int 19988Suppl 1:S8–12. [PubMed: 9682790]
49.
Marshall D, Johnell O, Wedel H Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254–9. [PMC free article: PMC2351094] [PubMed: 8634613]
50.
Hui SL, Slemenda CW, Carey MA, et al Choosing between predictors of fractures J Bone Miner Res 199510(11):1816–22. [PubMed: 8592960]
51.
Sackett DL, Richardson WS, Rosenberg W, et al Evidence-based medicine; how to practice and teach EBM. Edinburgh: Churchill Livingstone; 1998.
52.
Udvarhelyi I, Colditz G, Rai A, et al Cost-effectiveness and cost-benefit analyses in medical literature. Ann Intern Med. 1992;116:238–44. [PubMed: 1530808]
53.
Gold MR, Siegel JE, Russell LB, et al Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
54.
Cummings SR, Nevitt MC, Browner WS, et al Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group N Engl J Med 1995332(12):767–73. [PubMed: 7862179]
55.
Dargent-Molina P, Favier F, Grandjean H, et al Fall-related factors and risk of hip fracture: the EPIDOS prospective study Lancet 1996348(9021):145–9. [PubMed: 8684153]
56.
Dargent-Molina P, Schott AM, Hans D, et al Separate and combined value of bone mass and gait speed measurements in screening for hip fracture risk: results from the EPIDOS study. Epidemiologie de l'Osteoporose Osteoporos Int 19999(2):188–92. [PubMed: 10367048]
57.
Porter RW, Miller CG, Grainger D, et al Prediction of hip fracture in elderly women: a prospective study BMJ 1990301(6753):638–41. [PMC free article: PMC1663899] [PubMed: 2224217]
58.
Graafmans WC, Ooms ME, Bezemer PD, et al Different risk profiles for hip fractures and distal forearm fractures: a prospective study Osteoporos Int 19966(6):427–31. [PubMed: 9116386]
59.
Seeley DG, Kelsey J, Jergas M, et al Predictors of ankle and foot fractures in older women. The Study of Osteoporotic Fractures Research Group J Bone Miner Res 199611(9):1347–55. [PubMed: 8864910]
60.
Honkanen R, Tuppurainen M, Kroger H, et al Relationships between risk factors and fractures differ by type of fracture: a population-based study of 12,192 perimenopausal women Osteoporos Int 19988(1):25–31. [PubMed: 9692074]
61.
Mallmin H, Ljunghall S, Persson I, et al Risk factors for fractures of the distal forearm: a population-based case-control study Osteoporos Int 19944(6):298–304. [PubMed: 7696821]
62.
Tuppurainen M, Kroger H, Honkanen R, et al Risks of perimenopausal fractures--a prospective population-based study Acta Obstet Gynecol Scand 199574(8):624–8. [PubMed: 7660769]
63.
Cooper C, Shah S, Hand DJ, et al Screening for vertebral osteoporosis using individual risk factors. Osteoporos Int. 1991;2:48–53. [PubMed: 1790421]
64.
Orwoll ES, Bauer DC, Vogt TM, et al Axial bone mass in older women Ann Intern Med 1996124(2):187–96. [PubMed: 8533993]
65.
Bauer DC, Browner WS, Cauley JA, et al Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group Ann Intern Med 1993118(9):657–65. [PubMed: 8460853]
66.
Aloia JF, Vaswani A, Yeh JK, et al Risk for osteoporosis in black women Calcif Tissue Int 199659(6):415–23. [PubMed: 8939764]
67.
Tobias JH, Cook DG, Chambers TJ, et al A comparison of bone mineral density between Caucasian, Asian and Afro-Caribbean women Clin Sci 199487(5):587–91. [PubMed: 7874848]
68.
Evers SE, Orchard JW, Haddad RG Bone density in postmenopausal North American Indian and Caucasian females Hum Biol 198557(4):719–26. [PubMed: 4086025]
69.
Bauer RL Ethnic differences in hip fracture: a reduced incidence in Mexican Americans Am J Epidemiol 1988127(1):145–9. [PubMed: 3337072]
70.
Nakamura T, Turner CH, Yoshikawa T, et al Do variations in hip geometry explain differences in hip fracture risk between Japanese and white Americans? J Bone Miner Res 19949(7):1071–6. [PubMed: 7942154]
71.
Grisso JA, Kelsey JL, Strom BL, et al Risk factors for hip fracture in black women. The Northeast Hip Fracture Study Group N Engl J Med 1994330(22):1555–9. [PubMed: 8177244]
72.
Fujiwara S, Kasagi F, Yamada M, et al Risk factors for hip fracture in a Japanese cohort J Bone Miner Res 199712(7):998–1004. [PubMed: 9199997]
73.
Suzuki T, Yoshida H, Hashimoto T, et al Case-control study of risk factors for hip fractures in the Japanese elderly by a Mediterranean Osteoporosis Study (MEDOS) questionnaire Bone 199721(5):461–7. [PubMed: 9356741]
74.
Gunnes M, Lehmann EH, Mellstrom D, et al The relationship between anthropometric measurements and fractures in women Bone 199619(4):407–13. [PubMed: 8894148]
75.
Hemenway D, Feskanich D, Colditz GA Body height and hip fracture: a cohort study of 90,000 women Int J Epidemiol 199524(4):783–6. [PubMed: 8550276]
76.
Joakimsen RM, Fonnebo V, Magnus JH, et al The Tromso Study: body height, body mass index and fractures Osteoporos Int 19988(5):436–42. [PubMed: 9850351]
77.
Meyer HE, Tverdal A, Falch JA Risk factors for hip fracture in middle-aged Norwegian women and men Am J Epidemiol 1993137(11):1203–11. [PubMed: 8322761]
78.
Hunt AH The relationship between height change and bone mineral density Orthopaedic Nursing 199615(3):57–64; quiz 5-6. [PubMed: 8788647]
79.
Ravn P, Cizza G, Bjarnason NH, et al Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group J Bone Miner Res 199914(9):1622–7. [PubMed: 10469292]
80.
Albala C, Yanez M, Devoto E, et al Obesity as a protective factor for postmenopausal osteoporosis Int J Obes Relat Metab Disord 199620(11):1027–32. [PubMed: 8923160]
81.
Chen Z, Lohman TG, Stini WA, et al Fat or lean tissue mass: which one is the major determinant of bone mineral mass in healthy postmenopausal women? J Bone Miner Res 199712(1):144–51. [PubMed: 9240737]
82.
Khosla S, Atkinson EJ, Riggs BL, et al Relationship between body composition and bone mass in women J Bone Miner Res 199611(6):857–63. [PubMed: 8725184]
83.
Michaelsson K, Bergstrom R, Mallmin H, et al Screening for osteopenia and osteoporosis: selection by body composition Osteoporos Int 19966(2):120–6. [PubMed: 8704349]
84.
Marone MM, Gouveia CH, Lewin S, et al Influence of body composition on the bone mass of postmenopausal women Rev Paul Med 1997115(6):1580–8. [PubMed: 9640795]
85.
Takada H, Washino K, Iwata H Risk factors for low bone mineral density among females: the effect of lean body mass Prev Med 199726(5 Pt 1):633–8. [PubMed: 9327470]
86.
Meyer HE, Tverdal A, Falch JA Body height, body mass index, and fatal hip fractures: 16 years' follow-up of 674,000 Norwegian women and men Epidemiology 19956(3):299–305. [PubMed: 7619940]
87.
Johnell O, O'Neill T, Felsenberg D, et al Anthropometric measurements and vertebral deformities. European Vertebral Osteoporosis Study (EVOS) Group Am J Epidemiol 1997146(4):287–93. [PubMed: 9270407]
88.
Wolinsky FD, Fitzgerald JF The risk of hip fracture among noninstitutionalized older adults J Gerontol 199449(4):S165–75. [PubMed: 8014400]
89.
Grisso JA, Kelsey JL, Strom BL, et al Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group N Engl J Med 1991324(19):1326–31. [PubMed: 2017229]
90.
Bernstein J, Grisso JA, Kaplan FS Body mass and fracture risk. A study of 330 patients Clin Orthop 1999(364):227–30. [PubMed: 10416413]
91.
Ensrud KE, Cauley J, Lipschutz R, et al Weight change and fractures in older women. Study of Osteoporotic Fractures Research Group Arch Intern Med 1997157(8):857–63. [PubMed: 9129545]
92.
Meyer HE, Tverdal A, Falch JA Changes in body weight and incidence of hip fracture among middle aged Norwegians BMJ 1995311(6997):91–2. [PMC free article: PMC2550150] [PubMed: 7613409]
93.
French SA, Folsom AR, Jeffery RW, et al Weight variability and incident disease in older women: the Iowa Women's Health Study Int J Obes Relat Metab Disord 199721(3):217–23. [PubMed: 9080261]
94.
Meyer HE, Tverdal A, Selmer R Weight variability, weight change and the incidence of hip fracture: a prospective study of 39,000 middle-aged Norwegians Osteoporos Int 19988(4):373–8. [PubMed: 10024908]
95.
Langlois JA, Harris T, Looker AC, et al Weight change between age 50 years and old age is associated with risk of hip fracture in white women aged 67 years and older Arch Intern Med 1996156(9):989–94. [PubMed: 8624179]
96.
Pruzansky ME, Turano M, Luckey M, et al Low body weight as a risk factor for hip fracture in both black and white women J Orthop Res 19897(2):192–7. [PubMed: 2918419]
97.
Soroko SB, Barrett-Connor E, Edelstein SL, et al Family history of osteoporosis and bone mineral density at the axial skeleton: the Rancho Bernardo Study J Bone Miner Res 19949(6):761–9. [PubMed: 8079652]
98.
Grainge MJ, Coupland CA, Cliffe SJ, et al Association between a family history of fractures and bone mineral density in early postmenopausal women Bone 199924(5):507–12. [PubMed: 10321911]
99.
Fox KM, Cummings SR, Powell-Threets K, et al Family history and risk of osteoporotic fracture. Study of Osteoporotic Fractures Research Group Osteoporos Int 19988(6):557–62. [PubMed: 10326061]
100.
Seeman E, Hopper J, Bach L, et al Reduced bone mass in daughters of women with osteoporosis N Engl J Med 1989320(9):554–8. [PubMed: 2915666]
101.
Barthe N, Basse-Cathalinat B, Meunier PJ, et al Measurement of bone mineral density in mother-daughter pairs for evaluating the family influence on bone mass acquisition: a GRIO survey Osteoporos Int 19988(4):379–84. [PubMed: 10024909]
102.
Danielson ME, Cauley JA, Baker CE, et al Familial resemblance of bone mineral density (BMD) and calcaneal ultrasound attenuation: the BMD in mothers and daughters study J Bone Miner Res 199914(1):102–10. [PubMed: 9893071]
103.
Hansen MA, Hassager C, Jensen SB, et al Is heritability a risk factor for postmenopausal osteoporosis? J Bone Miner Res 19927(9):1037–43. [PubMed: 1414496]
104.
Pocock NA, Eisman JA, Hopper JL, et al Genetic determinants of bone mass in adults: a twin study. J Clin Invest. 1987;80:706–10. [PMC free article: PMC442294] [PubMed: 3624485]
105.
Arden NK, Baker J, Hogg C, et al The heritability of bone mineral density, ultrasound of the calcaneus and hip axis length: a study of postmenopausal twins J Bone Miner Res 199611(4):530–4. [PubMed: 8992884]
106.
Slemenda CW, Turner CH, Peacock M, et al The genetics of proximal femur geometry, distribution of bone mass and bone mineral density Osteoporos Int 19966(2):178–82. [PubMed: 8704359]
107.
Black DM, Arden NK, Palermo L, et al Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group J Bone Miner Res 199914(5):821–8. [PubMed: 10320531]
108.
Davis JW, Grove JS, Wasnich RD, et al Spatial relationships between prevalent and incident spine fractures Bone 199924(3):261–4. [PubMed: 10071920]
109.
Ross PD, Davis JW, Epstein RS, et al Pre-existing fractures and bone mass predict vertebral fracture incidence in women Ann Intern Med 1991114(11):919–23. [PubMed: 2024857]
110.
Ross PD, Genant HK, Davis JW, et al Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women Osteoporos Int 19933(3):120–6. [PubMed: 8481587]
111.
Wasnich RD, Davis JW, Ross PD Spine fracture risk is predicted by non-spine fractures Osteoporos Int 19944(1):1–5. [PubMed: 8148565]
112.
Lauritzen JB, Schwarz P, McNair P, et al Radial and humeral fractures as predictors of subsequent hip, radial or humeral fractures in women, and their seasonal variation Osteoporos Int 19933(3):133–7. [PubMed: 8481589]
113.
Mallmin H, Ljunghall S, Persson I, et al Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up Calcif Tissue Int 199352(4):269–72. [PubMed: 8467406]
114.
Finsen V, Benum P Colles' fracture as an indicator of increased risk of hip fracture. An epidemiological study Ann Chir Gynaecol 198776(2):114–8. [PubMed: 3497604]
115.
Cuddihy MT, Gabriel SE, Crowson CS, et al Forearm fractures as predictors of subsequent osteoporotic fractures. Osteoporos Int. 1999;9:469–75. [PubMed: 10624452]
116.
Honkanen R, Tuppurainen M, Kroger H, et al Associations of early premenopausal fractures with subsequent fractures vary by sites and mechanisms of fractures Calcif Tissue Int 199760(4):327–31. [PubMed: 9075627]
117.
Gunnes M, Mellstrom D, Johnell O How well can a previous fracture indicate a new fracture? A questionnaire study of 29,802 postmenopausal women Acta Orthop Scand 199869(5):508–12. [PubMed: 9855234]
118.
Burger H, van Daele PL, Algra D, et al Vertebral deformities as predictors of non-vertebral fractures BMJ 1994309(6960):991–2. [PMC free article: PMC2541289] [PubMed: 7950721]
119.
Karlsson MK, Hasserius R, Obrant KJ Individuals who sustain nonosteoporotic fractures continue to also sustain fragility fractures Calcif Tissue Int 199353(4):229–31. [PubMed: 8275349]
120.
Lauritzen JB, Lund B Risk of hip fracture after osteoporosis fractures. 451 women with fracture of lumbar spine, olecranon, knee or ankle Acta Orthop Scand 199364(3):297–300. [PubMed: 8322584]
121.
Ribot C, Tremollieres F, Pouilles JM, et al Risk factors for hip fracture. MEDOS study: results of the Toulouse Centre Bone 199314Suppl 1:S77–80. [PubMed: 8110526]
122.
Law MR, Hackshaw AK A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect BMJ 1997315(7112):841–6. [PMC free article: PMC2127590] [PubMed: 9353503]
123.
Hopper JL, Seeman E The bone density of female twins discordant for tobacco use N Engl J Med 1994330(6):387–92. [PubMed: 8284003]
124.
Cornuz J, Feskanich D, Willett WC, et al Smoking, smoking cessation, and risk of hip fracture in women Am J Med 1999106(3):311–4. [PubMed: 10190380]
125.
Forsen L, Bjorndal A, Bjartveit K, et al Interaction between current smoking, leanness, and physical inactivity in the prediction of hip fracture J Bone Miner Res 19949(11):1671–8. [PubMed: 7863817]
126.
Kiel DP, Baron JA, Anderson JJ, et al Smoking eliminates the protective effect of oral estrogens on the risk for hip fracture among women Ann Intern Med 1992116(9):716–21. [PubMed: 1558342]
127.
Melhus H, Michaelsson K, Holmberg L, et al Smoking, antioxidant vitamins, and the risk of hip fracture J Bone Miner Res 199914(1):129–35. [PubMed: 9893075]
128.
Diaz MN, O'Neill TW, Silman AJ The influence of family history of hip fracture on the risk of vertebral deformity in men and women: the European Vertebral Osteoporosis Study Bone 199720(2):145–9. [PubMed: 9028539]
129.
Grainge MJ, Coupland CA, Cliffe SJ, et al Cigarette smoking, alcohol and caffeine consumption, and bone mineral density in postmenopausal women. The Nottingham EPIC Study Group Osteoporos Int 19988(4):355–63. [PubMed: 10024906]
130.
Hoidrup S, Gronbaek M, Gottschau A, et al Alcohol intake, beverage preference, and risk of hip fracture in men and women. Copenhagen Centre for Prospective Population Studies Am J Epidemiol 1999149(11):993–1001. [PubMed: 10355374]
131.
Hemenway D, Colditz G, Willett W, et al Fractures and lifestyle: effect of cigarette smoking, alcohol intake, and relative weight on the risk of hip and forearm fractures in middle-aged women. Am J Public Health. 1988;78:1554–8. [PMC free article: PMC1349734] [PubMed: 3189632]
132.
Felson DT, Zhang Y, Hannan MT, et al Alcohol intake and bone mineral density in elderly men and women. The Framingham Study Am J Epidemiol 1995142(5):485–92. [PubMed: 7677127]
133.
Felson DT, Kiel DP, Anderson JJ, et al Alcohol consumption and hip fractures: the Framingham Study Am J Epidemiol 1988128(5):1102–10. [PubMed: 3189283]
134.
Barrett-Connor E, Chang J, Edelstein S Coffee-associated osteoporosis offset by daily milk consumption. The Rancho Bernardo Study. JAMA. 1994;271:280–3. [PubMed: 8295286]
135.
Harris S, Dawson-Hughes B Caffeine and bone loss in healthy postmenopausal women. Am J Clin Nutr. 1994;60:573–8. [PubMed: 8092093]
136.
Lloyd T, Rollings N, Eggli DF, et al Dietary caffeine intake and bone status of postmenopausal women Am J Clin Nutr 199765(6):1826–30. [PubMed: 9174479]
137.
Johansson C, Mellstrom D, Lerner U, et al Coffee drinking: a minor risk factor for bone loss and fractures Age Ageing 199221(1):20–6. [PubMed: 1553855]
138.
Tavani A, Negri E, La Vecchia C Coffee intake and risk of hip fracture in women in northern Italy Prev Med 199524(4):396–400. [PubMed: 7479631]
139.
Kiel DP, Felson DT, Hannan MT, et al Caffeine and the risk of hip fracture: the Framingham Study Am J Epidemiol 1990132(4):675–84. [PubMed: 2403108]
140.
Hernandez-Avila M, Colditz GA, Stampfer MJ, et al Caffeine, moderate alcohol intake, and risk of fractures of the hip and forearm in middle-aged women Am J Clin Nutr 199154(1):157–63. [PubMed: 2058578]
141.
Chapuy MC, Arlot ME, Duboeuf F, et al Vitamin D3 and calcium to prevent hip fractures in the elderly women N Engl J Med 1992327(23):1637–42. [PubMed: 1331788]
142.
Dawson-Hughes B, Harris SS, Krall EA, et al Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older N Engl J Med 1997337(10):670–6. [PubMed: 9278463]
143.
Earnshaw SA, Worley A, Hosking DJ Current diet does not relate to bone mineral density after the menopause. The Nottingham Early Postmenopausal Intervention Cohort (EPIC) Study Group Br J Nutr 199778(1):65–72. [PubMed: 9292760]
144.
Cooper C, Barker DJP, Wickham C Physical activity, muscle strength, and calcium intake in fracture of the proximal femur in Britain. BMJ. 1988;297:1443–6. [PMC free article: PMC1835123] [PubMed: 3147008]
145.
Tavani A, Negri E, La Vecchia C Calcium, dairy products, and the risk of hip fracture in women in northern Italy Epidemiology 19956(5):554–7. [PubMed: 8562636]
146.
Feskanich D, Willett WC, Stampfer MJ, et al Milk, dietary calcium, and bone fractures in women: a 12-year prospective study Am J Public Health 199787(6):992–7. [PMC free article: PMC1380936] [PubMed: 9224182]
147.
Wickham CA, Walsh K, Cooper C, et al Dietary calcium, physical activity, and risk of hip fracture: a prospective study BMJ 1989299(6704):889–92. [PMC free article: PMC1837771] [PubMed: 2510879]
148.
Looker AC, Harris TB, Madans JH, et al Dietary calcium and hip fracture risk: the NHANES I Epidemiologic Follow-Up Study Osteoporos Int 19933(4):177–84. [PubMed: 8338972]
149.
Stracke H, Renner E, Knie G, et al Osteoporosis and bone metabolic parameters in dependence upon calcium intake through milk and milk products Eur J Clin Nutr 199347(9):617–22. [PubMed: 8243426]
150.
Sandler RB, Slemenda CW, LaPorte RE, et al Postmenopausal bone density and milk consumption in childhood and adolescence Am J Clin Nutr 198542(2):270–4. [PubMed: 3839625]
151.
Michaelsson K, Bergstrom R, Holmberg L, et al A high dietary calcium intake is needed for a positive effect on bone density in Swedish postmenopausal women Osteoporos Int 19977(2):155–61. [PubMed: 9166397]
152.
Aptel I, Cance-Rouzaud A, Grandjean H Association between calcium ingested from drinking water and femoral bone density in elderly women: evidence from the EPIDOS cohort J Bone Miner Res 199914(5):829–33. [PubMed: 10320532]
153.
Holbrook T, Barrett-Connor E An 18-year prospective study of dietary calcium and bone mineral density in the hip. Calcif Tissue Int. 1995;56:364–7. [PubMed: 7621342]
154.
Lau EM, Cooper C Epidemiology and prevention of osteoporosis in urbanized Asian populations. Osteoporos Int. 1993;3 Suppl 1:23–6. [PubMed: 8461569]
155.
Holbrook TL, Barrett-Connor E, Wingard DL Dietary calcium and risk of hip fracture: 14-year prospective population study Lancet 19882(8619):1046–9. [PubMed: 2903278]
156.
Johnell O, Gullberg B, Kanis JA, et al Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study J Bone Miner Res 199510(11):1802–15. [PubMed: 8592959]
157.
Komar L, Nieves J, Cosman F, et al Calcium homeostasis of an elderly population upon admission to a nursing home J Am Geriatr Soc 199341(10):1057–64. [PubMed: 8409150]
158.
Ranstam J, Kanis JA Influence of age and body mass on the effects of vitamin D on hip fracture risk Osteoporos Int 19955(6):450–4. [PubMed: 8695967]
159.
Jones G, Riley M, Couper D, et al Water fluoridation, bone mass and fracture: a quantitative overview of the literature Aust N Z J Public Health 199923(1):34–40. [PubMed: 10083687]
160.
Sowers MF, Clark MK, Jannausch ML, et al A prospective study of bone mineral content and fracture in communities with differential fluoride exposure Am J Epidemiol 1991133(7):649–60. [PubMed: 2018020]
161.
Karagas MR, Baron JA, Barrett JA, et al Patterns of fracture among the United States elderly: geographic and fluoride effects Ann Epidemiol 19966(3):209–16. [PubMed: 8827156]
162.
Feskanich D, Owusu W, Hunter DJ, et al Use of toenail fluoride levels as an indicator for the risk of hip and forearm fractures in women Epidemiology 19989(4):412–6. [PubMed: 9647905]
163.
Cauley JA, Murphy PA, Riley TJ, et al Effects of fluoridated drinking water on bone mass and fractures: the study of osteoporotic fractures J Bone Miner Res 199510(7):1076–86. [PubMed: 7484283]
164.
Foley KT, Owings TM, Pavol MJ, et al Maximum grip strength is not related to bone mineral density of the proximal femur in older adults Calcif Tissue Int 199964(4):291–4. [PubMed: 10089220]
165.
Kritz-Silverstein D, Barrett-Connor E Grip strength and bone mineral density in older women J Bone Miner Res 19949(1):45–51. [PubMed: 8154308]
166.
Lau EM, Woo J, Leung PC, et al Low bone mineral density, grip strength and skinfold thickness are important risk factors for hip fracture in Hong Kong Chinese Osteoporos Int 19933(2):66–70. [PubMed: 8453192]
167.
Meyer HE, Henriksen C, Falch JA, et al Risk factors for hip fracture in a high incidence area: a case-control study from Oslo, Norway Osteoporos Int 19955(4):239–46. [PubMed: 7492862]
168.
Elliot JR, Hanger HC, Gilchrist NL, et al A comparison of elderly patients with proximal femoral fractures and a normal elderly population: a case control study N Z Med J 1992105(944):420–2. [PubMed: 1297935]
169.
Nguyen T, Sambrook P, Kelly P, et al Prediction of osteoporotic fractures by postural instability and bone density BMJ 1993307(6912):1111–5. [PMC free article: PMC1679116] [PubMed: 8251809]
170.
Felson DT, Anderson JJ, Hannan MT, et al Impaired vision and hip fracture. The Framingham Study J Am Geriatr Soc 198937(6):495–500. [PubMed: 2715555]
171.
Klein BE, Klein R, Lee KE, et al Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study Ophthalmology 1998105(1):160–4. [PubMed: 9442793]
172.
Coupland CA, Cliffe SJ, Bassey EJ, et al Habitual physical activity and bone mineral density in postmenopausal women in England Int J Epidemiol 199928(2):241–6. [PubMed: 10342685]
173.
Uusi-Rasi K, Sievanen H, Vuori I, et al Long-term recreational gymnastics, estrogen use, and selected risk factors for osteoporotic fractures J Bone Miner Res 199914(7):1231–8. [PubMed: 10404026]
174.
Hoshino H, Kushida K, Yamazaki K, et al Effect of physical activity as a caddie on ultrasound measurements of the Os calcis: a cross-sectional comparison J Bone Miner Res 199611(3):412–8. [PubMed: 8852953]
175.
Bidoli E, Schinella D, Franceschi S Physical activity and bone mineral density in Italian middle-aged women Eur J Epidemiol 199814(2):153–7. [PubMed: 9556174]
176.
Jaglal SB, Kreiger N, Darlington GA Lifetime occupational physical activity and risk of hip fracture in women Ann Epidemiol 19955(4):321–4. [PubMed: 8520716]
177.
Gregg EW, Cauley JA, Seeley DG, et al Physical activity and osteoporotic fracture risk in older women. Study of Osteoporotic Fractures Research Group Ann Intern Med 1998129(2):81–8. [PubMed: 9669990]
178.
Paganini-Hill A, Chao A, Ross RK, et al Exercise and other factors in the prevention of hip fracture: the Leisure World study Epidemiology 19912(1):16–25. [PubMed: 2021661]
179.
Coupland C, Wood D, Cooper C Physical inactivity is an independent risk factor for hip fracture in the elderly J Epidemiol Community Health 199347(6):441–3. [PMC free article: PMC1059855] [PubMed: 8120496]
180.
Lau E, Donnan S, Barker DJP, et al Physical activity and calcium intake in fracture of the proximal femur in Hong Kong. BMJ. 1988;297:1441–3. [PMC free article: PMC1835159] [PubMed: 3147007]
181.
Stevens JA, Powell KE, Smith SM, et al Physical activity, functional limitations, and the risk of fall-related fractures in community-dwelling elderly Ann Epidemiol 19977(1):54–61. [PubMed: 9034407]
182.
Jaglal SB, Kreiger N, Darlington G Past and recent physical activity and risk of hip fracture Am J Epidemiol 1993138(2):107–18. [PubMed: 8342529]
183.
Boyce WJ, Vessey MP Habitual physical inertia and other factors in relation to risk of fracture of the proximal femur Age Ageing 198817(5):319–27. [PubMed: 3232586]
184.
Khan KM, Green RM, Saul A, et al Retired elite female ballet dancers and nonathletic controls have similar bone mineral density at weightbearing sites J Bone Miner Res 199611(10):1566–74. [PubMed: 8889858]
185.
Khan KM, Bennell KL, Hopper JL, et al Self-reported ballet classes undertaken at age 10-12 years and hip bone mineral density in later life Osteoporos Int 19988(2):165–73. [PubMed: 9666941]
186.
Puntila E, Kroger H, Lakka T, et al Physical activity in adolescence and bone density in peri- and postmenopausal women: a population-based study Bone 199721(4):363–7. [PubMed: 9315340]
187.
Nieves JW, Grisso JA, Kelsey JL A case-control study of hip fracture: evaluation of selected dietary variables and teenage physical activity Osteoporos Int 19922(3):122–7. [PubMed: 1627898]
188.
Suen LK Occupation and risk of hip fracture J Public Health Med 199820(4):428–33. [PubMed: 9923950]
189.
Gardsell P, Johnell O, Nilsson BE, et al The predictive value of fracture, disease, and falling tendency for fragility fractures in women Calcif Tissue Int 198945(6):327–30. [PubMed: 2509022]
190.
Cooper C, Barker DJ, Morris J, et al Osteoporosis, falls, and age in fracture of the proximal femur Br Med J (Clin Res Ed) 1987295(6589):13–5. [PMC free article: PMC1246898] [PubMed: 3113595]
191.
Lau E, Donnan S Falls and hip fracture in Hong Kong Chinese. Pub Health. 1990;104:117–21. [PubMed: 2359827]
192.
Cumming RG, Klineberg RJ Fall frequency and characteristics and the risk of hip fractures J Am Geriatr Soc 199442(7):774–8. [PubMed: 8014355]
193.
Greenspan SL, Myers ER, Kiel DP, et al Fall direction, bone mineral density, and function: risk factors for hip fracture in frail nursing home elderly Am J Med 1998104(6):539–45. [PubMed: 9674716]
194.
Jarnlo GB, Thorngren KG Background factors to hip fractures Clin Orthop 1993. (287):41–9. [PubMed: 8448959]
195.
Norton R, Campbell AJ, Lee-Joe T, et al Circumstances of falls resulting in hip fractures among older people J Am Geriatr Soc 199745(9):1108–12. [PubMed: 9288020]
196.
Clemson L, Cumming RG, Roland M Case-control study of hazards in the home and risk of falls and hip fractures Age Ageing 199625(2):97–101. [PubMed: 8670535]
197.
Luukinen H, Koski K, Laippala P, et al Factors predicting fractures during falling impacts among home-dwelling older adults J Am Geriatr Soc 199745(11):1302–9. [PubMed: 9361654]
198.
Yaffe K, Browner W, Cauley J, et al Association between bone mineral density and cognitive decline in older women J Am Geriatr Soc 199947(10):1176–82. [PubMed: 10522949]
199.
Johansson C, Skoog I A population-based study on the association between dementia and hip fractures in 85-year olds Aging (Milano) 19968(3):189–96. [PMC free article: PMC305699] [PubMed: 8862194]
200.
Melton LJ 3rd, Beard CM, Kokmen E, et al Fracture risk in patients with Alzheimer's disease. J Am Geriatr Soc. 1994;42:614–9. [PubMed: 8201146]
201.
Guo Z, Wills P, Viitanen M, et al Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study Am J Epidemiol 1998148(9):887–92. [PubMed: 9801019]
202.
Schweiger U, Deuschle M, Korner A, et al Low lumbar bone mineral density in patients with major depression Am J Psychiatry 1994151(11):1691–3. [PubMed: 7943462]
203.
Michelson D, Stratakis C, Hill L, et al Bone mineral density in women with depression N Engl J Med 1996335(16):1176–81. [PubMed: 8815939]
204.
Whooley MA, Kip KE, Cauley JA, et al Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group Arch Intern Med 1999159(5):484–90. [PubMed: 10074957]
205.
Ito M, Yamada M, Hayashi K, et al Relation of early menarche to high bone mineral density Calcif Tissue Int 199557(1):11–4. [PubMed: 7671158]
206.
Osei-Hyiaman D, Satoshi T, Ueji M, et al Timing of menopause, reproductive years, and bone mineral density: a cross-sectional study of postmenopausal Japanese women Am J Epidemiol 1998148(11):1055–61. [PubMed: 9850127]
207.
Parazzini F, Bidoli E, Franceschi S, et al Menopause, menstrual and reproductive history, and bone density in northern Italy J Epidemiol Community Health 199650(5):519–23. [PMC free article: PMC1060342] [PubMed: 8944857]
208.
Ohta H, Sugimoto I, Masuda A, et al Decreased bone mineral density associated with early menopause progresses for at least ten years: cross-sectional comparisons between early and normal menopausal women Bone 199618(3):227–31. [PubMed: 8703577]
209.
Bagur AC, Mautalen CA Risk for developing osteoporosis in untreated premature menopause Calcif Tissue Int 199251(1):4–7. [PubMed: 1393775]
210.
Pouilles JM, Tremollieres F, Bonneu M, et al Influence of early age at menopause on vertebral bone mass J Bone Miner Res 19949(3):311–5. [PubMed: 8191923]
211.
Tuppurainen M, Honkanen R, Kroger H, et al Osteoporosis risk factors, gynaecological history and fractures in perimenopausal women -- the results of the baseline postal enquiry of the Kuopio Osteoporosis Risk Factor and Prevention Study Maturitas 199317(2):89–100. [PubMed: 8231907]
212.
O'Neill TW, Silman AJ, Naves Diaz M, et al Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women. European Vertebral Osteoporosis Study Group Osteoporos Int 19977(1):72–8. [PubMed: 9102068]
213.
Cumming RG, Klineberg RJ Breastfeeding and other reproductive factors and the risk of hip fractures in elderly women Int J Epidemiol 199322(4):684–91. [PubMed: 8225744]
214.
Melton LJ 3rd, Bryant SC, Wahner HW, et al Influence of breastfeeding and other reproductive factors on bone mass later in life Osteoporos Int 19933(2):76–83. [PubMed: 8453194]
215.
Felson DT, Zhang Y, Hannan MT, et al The effect of postmenopausal estrogen therapy on bone density in elderly women N Engl J Med 1993329(16):1141–6. [PubMed: 8377776]
216.
Cauley JA, Seeley DG, Ensrud K, et al Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group Ann Intern Med 1995122(1):9–16. [PubMed: 7985914]
217.
Naessen T, Persson I, Adami HO, et al Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study Ann Intern Med 1990113(2):95–103. [PubMed: 2360759]
218.
Kiel DP, Felson DT, Anderson JJ, et al Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study N Engl J Med 1987317(19):1169–74. [PubMed: 3657888]
219.
Johnson RE, Specht EE The risk of hip fracture in postmenopausal females with or without estrogen drug exposure Am J Public Health 198171(2):138–44. [PMC free article: PMC1619634] [PubMed: 7457682]
220.
Grodstein F, Stampfer MJ, Falkeborn M, et al Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women Epidemiology 199910(5):476–80. [PubMed: 10468418]
221.
Michaelsson K, Baron JA, Johnell O, et al Variation in the efficacy of hormone replacement therapy in the prevention of hip fracture. Osteoporos Int. 1998;8:540–6. [PubMed: 10326058]
222.
Maxim P, Ettinger B, Spitalny GM Fracture protection by long-term estrogen treatment. Osteoporos Int. 1995;5:23–9. [PubMed: 7703620]
223.
Kleerekoper M, Brienza RS, Schultz LR, et al Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group Arch Intern Med 1991151(10):1971–6. [PubMed: 1929685]
224.
Tuppurainen M, Kröger H, Saarikoski S, et al The effect of previous oral contraceptive use on bone mineral density in perimenopausal women. Osteoporos Int. 1994;4:93–8. [PubMed: 8003847]
225.
Cooper C, Hannaford P, Croft P, et al Oral contraceptive pill use and fractures in women: a prospective study Bone 199314(1):41–5. [PubMed: 8443001]
226.
Fox KM, Cummings SR Is tubal ligation a risk factor for low bone density and increased risk of fracture? Am J Obstet Gynecol 1995172(1 Pt 1):101–5. [PubMed: 7847513]
227.
Alderman B, Weiss N, Daling J, et al Reproductive history and postmenopausal risk of hip and forearm fracture Am J Epidemiol 1986124(2):262–7. [PubMed: 3728442]
228.
Hamed HM, Purdie DW, Steel SA, et al The relation between bone mineral density and early pregnancy loss Br J Obstet Gynaecol 199299(12):946–9. [PubMed: 1477013]
229.
Feldblum PJ, Zhang J, Rich LE, et al Lactation history and bone mineral density among perimenopausal women Epidemiology 19923(6):527–31. [PubMed: 1420520]
230.
Jones G, Nguyen T, Sambrook PN, et al Thiazide diuretics and fractures: can meta-analysis help? J Bone Miner Res 199510(1):106–11. [PubMed: 7747616]
231.
Cauley JA, Cummings SR, Seeley DG, et al Effects of thiazide diuretic therapy on bone mass, fractures, and falls. The Study of Osteoporotic Fractures Research Group Ann Intern Med 1993118(9):666–73. [PubMed: 8489642]
232.
Feskanich D, Willett WC, Stampfer MJ, et al A prospective study of thiazide use and fractures in women Osteoporos Int 19977(1):79–84. [PubMed: 9102069]
233.
Heidrich FE, Stergachis A, Gross KM Diuretic drug use and the risk for hip fracture Ann Intern Med 1991115(1):1–6. [PubMed: 2048857]
234.
Stall GM, Harris S, Sokoll LJ, et al Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine Ann Intern Med 1990113(4):265–9. [PubMed: 2375563]
235.
Schneider DL, Barrett-Connor EL, Morton DJ Thyroid hormone use and bone mineral density in elderly women. Effects of estrogen JAMA 1994271(16):1245–9. [PubMed: 7848399]
236.
Fowler PB, McIvor J, Sykes L, et al The effect of long-term thyroxine on bone mineral density and serum cholesterol J R Coll Physicians Lond 199630(6):527–32. [PMC free article: PMC5401510] [PubMed: 8961207]
237.
Franklyn J, Betteridge J, Holder R, et al Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis Clin Endocrinol 199441(4):425–32. [PubMed: 7955453]
238.
Franklyn JA, Betteridge J, Daykin J, et al Long-term thyroxine treatment and bone mineral density Lancet 1992340(8810):9–13. [PubMed: 1351654]
239.
Greenspan SL, Greenspan FS The effect of thyroid hormone on skeletal integrity Ann Intern Med 1999130(9):750–8. [PubMed: 10357695]
240.
Meier CR, Schlienger RG, Kraenzlin ME, et al HMG-CoA reductase inhibitors and the risk of fractures. JAMA. 2000;283:3205–10. [PubMed: 10866867]
241.
Wang PS, Solomon DH, Mogun H, et al HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA. 2000;283:3211–6. [PubMed: 10866868]
242.
Liu B, Anderson G, Mittmann N, et al Use of selective serotonin-reuptake inhibitors of tricyclic antidepressants and risk of hip fractures in elderly people Lancet 1998351(9112):1303–7. [PubMed: 9643791]
243.
Ray WA, Griffin MR, Malcolm E Cyclic antidepressants and the risk of hip fracture Arch Intern Med 1991151(4):754–6. [PubMed: 2012459]
244.
Ray W, Griffin M, Schaffner W, et al Psychotropic drug use and the risk of hip fracture N Engl J Med 1987316(7):363–9. [PubMed: 2880292]
245.
Jacqmin-Gadda H, Fourrier A, Commenges D, et al Risk factors for fractures in the elderly Epidemiology 19989(4):417–23. [PubMed: 9647906]
246.
Cohen O, Rais T, Lepkifker E, et al Lithium carbonate therapy is not a risk factor for osteoporosis Horm Metab Res 199830(9):594–7. [PubMed: 9808330]
247.
Morton DJ, Barrett-Connor EL, Schneider DL Nonsteroidal anti-inflammatory drugs and bone mineral density in older women: the Rancho Bernardo study J Bone Miner Res 199813(12):1924–31. [PubMed: 9844111]
248.
Bauer DC, Orwoll ES, Fox KM, et al Aspirin and NSAID use in older women: effect on bone mineral density and fracture risk. Study of Osteoporotic Fractures Research Group J Bone Miner Res 199611(1):29–35. [PubMed: 8770694]
249.
Cumming RG, Klineberg RJ Psychotropics, thiazide diuretics and hip fractures in the elderly Med J Aust 1993158(6):414–7. [PubMed: 8479356]
250.
Herings RM, Stricker BH, de Boer A, et al Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life Arch Intern Med 1995155(16):1801–7. [PubMed: 7654115]
251.
Ray WA, Griffin MR, Downey W Benzodiazepines of long and short elimination half-life and the risk of hip fracture JAMA 1989262(23):3303–7. [PubMed: 2573741]
252.
Cummings SR Are patients with hip fractures more osteoporotic? Review of the evidence Am J Med 198578(3):487–94. [PubMed: 3976707]
253.
Wysowski DK, Baum C, Ferguson WJ, et al Sedative-hypnotic drugs and the risk of hip fracture J Clin Epidemiol 199649(1):111–3. [PubMed: 8598503]
254.
Stevens A, Mulrow C Drugs affecting postural stability and other risk factors in the hip fracture epidemic -- case-control study Community Med 198911(1):27–34. [PubMed: 2721145]
255.
Caraballo PJ, Heit JA, Atkinson EJ, et al Long-term use of oral anticoagulants and the risk of fracture Arch Intern Med 1999159(15):1750–6. [PubMed: 10448778]
256.
Jamal SA, Browner WS, Bauer DC, et al Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group Ann Intern Med 1998128(10):829–32. [PubMed: 9599195]
257.
Adachi Y, Shiota E, Matsumata T, et al Bone mineral density in patients taking H2-receptor antagonist Calcif Tissue Int 199862(4):283–5. [PubMed: 9504949]
258.
Jamal SA, Browner WS, Bauer DC, et al Intermittent use of nitrates increases bone mineral density: the study of osteoporotic fractures J Bone Miner Res 199813(11):1755–9. [PubMed: 9797485]
259.
Ross PD, Wasnich RD, Davis JW Fracture prediction models for osteoporosis prevention Bone 199011(5):327–31. [PubMed: 2123644]
260.
van Hemert AM, Vandenbroucke JP, Birkenhager JC, et al Prediction of osteoporotic fractures in the general population by a fracture risk score. A 9-year follow-up among middle-aged women Am J Epidemiol 1990132(1):123–35. [PubMed: 2192546]
261.
Ranstam J, Elffors L, Kanis JA A mental-functional risk score for prediction of hip fracture Age Ageing 199625(6):439–42. [PubMed: 9003879]
262.
Burger H, de Laet CE, Weel AE, et al Added value of bone mineral density in hip fracture risk scores Bone 199925(3):369–74. [PubMed: 10495142]
263.
Tromp AM, Smit JH, Deeg DJ, et al Predictors for falls and fractures in the Longitudinal Aging Study Amsterdam J Bone Miner Res 199813(12):1932–9. [PubMed: 9844112]
264.
Kleerekoper M, Peterson E, Nelson D, et al Identification of women at risk for developing postmenopausal osteoporosis with vertebral fractures: role of history and single photon absorptiometry Bone Miner 19897(2):171–86. [PubMed: 2804452]
265.
Falch JA, Sandvik L, Van Beresteijn EC Development and evaluation of an index to predict early postmenopausal bone loss Bone 199213(4):337–41. [PubMed: 1389575]
266.
Verhaar HJ, Koele JJ, Neijzen T, et al Are arm span measurements useful in the prediction of osteoporosis in postmenopausal women? Osteoporos Int 19988(2):174–6. [PubMed: 9666942]
267.
Elliot JR, Gilchrist NL, Wells JE, et al Historical assessment of risk factors in screening for osteopenia in a normal Caucasian population Aust N Z J Med 199323(5):458–62. [PubMed: 8297274]
268.
Ballard PA, Purdie DW, Langton CM, et al Prevalence of osteoporosis and related risk factors in UK women in the seventh decade: osteoporosis case finding by clinical referral criteria or predictive model? Osteoporos Int 19988(6):535–9. [PubMed: 10326057]
269.
Ribot C, Pouilles JM, Bonneu M, et al Assessment of the risk of post-menopausal osteoporosis using clinical factors Clin Endocrinol 199236(3):225–8. [PubMed: 1563075]
270.
Slemenda CW, Hui SL, Longcope C, et al Predictors of bone mass in perimenopausal women. A prospective study of clinical data using photon absorptiometry Ann Intern Med 1990112(2):96–101. [PubMed: 2294827]
271.
Lydick E, Cook K, Turpin J, et al Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density Am J Manag Care 19984(1):37–48. [PubMed: 10179905]
272.
Goemaere S, Zegels B, Toye K, et al Limited clinical utility of a self-evaluating risk assessment scale for postmenopausal osteoporosis: lack of predictive value of lifestyle-related factors. Calcif Tissue Int. 1999;65:354–8. [PubMed: 10541759]
273.
Hanley JA, McNeil BJ The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36. [PubMed: 7063747]
274.
Von Mühlen D, Visby Lunde A, Barrett-Connor E, et al Evaluation of the simple calculated osteoporosis risk estimation (SCORE) in older Caucasian women: the Rancho Bernardo study. Osteoporos Int. 1999;10:79–84. [PubMed: 10501784]
275.
Epstein RS, Feng W, Hirsch LJ, et al Intervention thresholds for the treatment of osteoporosis: comparison of different approaches to decision-making Osteoporos Int 19988Suppl 1:S22–7. [PubMed: 9682793]
276.
Black DM, Cummings SR, Karpf DB, et al Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet. 1996;348:1535–41. [PubMed: 8950879]
277.
Liberman UA, Weiss SR, Broll J, et al Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis N Engl J Med 1995333(22):1437–43. [PubMed: 7477143]
278.
Adami S, Passeri M, Ortolani S, et al Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis Bone 199517(4):383–90. [PubMed: 8573412]
279.
Pols HA, Felsenberg D, Hanley DA, et al Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Foxamax International Trial Study Group Osteoporos Int 19999(5):461–8. [PubMed: 10550467]
280.
Bone HG, Downs RW Jr., Tucci JR, et al Dose-response relationships for alendronate treatment in osteoporotic elderly women J Clin Endocrinol Metab 199782(1):265–74. [PubMed: 8989272]
281.
Chesnut CH 3rd, McClung MR, Ensrud KE, et al Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling Am J Med 199599(2):144–52. [PubMed: 7625419]
282.
Greenspan SL, Parker RA, Ferguson L, et al Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial J Bone Miner Res 199813(9):1431–8. [PubMed: 9738515]
283.
Cummings SR, Black DM, Thompson DE Effect of alendronate reduces on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial JAMA 1998280(24):2077–82. [PubMed: 9875874]
284.
Melton LJ 3rd, Atkinson EJ, O'Fallon WM, et al Long-term fracture prediction by bone mineral assessed at different skeletal sites J Bone Miner Res 19938(10):1227–33. [PubMed: 8256660]
285.
Black DM, Cummings SR, Genant HK, et al Axial and appendicular bone density predict fractures in older women J Bone Miner Res 19927(6):633–8. [PubMed: 1414481]
286.
Cummings SR, Black DM, Nevitt MC, et al Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group JAMA 1990263(5):665–8. [PubMed: 2404146]
287.
Hui SL, Slemenda CW, Johnston CC Jr Baseline measurement of bone mass predicts fracture in white women Ann Intern Med 1989111(5):355–61. [PubMed: 2764403]
288.
Hui SL, Slemenda CW, Johnston CC Jr Age and bone mass as predictors of fracture in a prospective study J Clin Invest 198881(6):1804–9. [PMC free article: PMC442628] [PubMed: 3384952]
289.
Cleghorn D, Polley K, Bellon M, et al Fracture rates as a function of forearm mineral density in normal postmenopausal women: retrospective and prospective data. Calcif Tissue Int. 1991;49:161–3. [PubMed: 1933579]
290.
Bauer DC, Gluer CC, Cauley JA, et al Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study. Study of Osteoporotic Fractures Research Group Arch Intern Med 1997157(6):629–34. [PubMed: 9080917]
291.
de Laet CE, Van Hout BA, Burger H, et al Hip fracture prediction in elderly men and women: validation in the Rotterdam study J Bone Miner Res 199813(10):1587–93. [PubMed: 9783547]
292.
Duboeuf F, Hans D, Schott AM, et al Different morphometric and densitometric parameters predict cervical and trochanteric hip fracture: the EPIDOS Study J Bone Miner Res 199712(11):1895–902. [PubMed: 9383694]
293.
Garnero P, Dargent-Molina P, Hans D, et al Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women? The EPIDOS prospective study Osteoporos Int 19988(6):563–9. [PubMed: 10326062]
294.
Hans D, Dargent-Molina P, Schott AM, et al Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study Lancet 1996348(9026):511–4. [PubMed: 8757153]
295.
Kroger H, Huopio J, Honkanen R, et al Prediction of fracture risk using axial bone mineral density in a perimenopausal population: a prospective study J Bone Miner Res 199510(2):302–6. [PubMed: 7754811]
296.
Mele R, Masci G, Ventura V, et al Three-year longitudinal study with quantitative ultrasound at the hand phalanx in a female population Osteoporos Int 19977(6):550–7. [PubMed: 9604051]
297.
Nevitt MC, Johnell O, Black DM, et al Bone mineral density predicts non-spine fractures in very elderly women. Study of Osteoporotic Fractures Research Group Osteoporos Int 19944(6):325–31. [PubMed: 7696827]
298.
Schott AM, Cormier C, Hans D, et al How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS Prospective Study Osteoporos Int 19988(3):247–54. [PubMed: 9797909]
299.
Stewart A, Torgerson DJ, Reid DM Prediction of fractures in perimenopausal women: a comparison of dual energy x ray absorptiometry and broadband ultrasound attenuation. Ann Rheum Dis. 1996;55:140–2. [PMC free article: PMC1010110] [PubMed: 8712866]
300.
Vecht-Hart CM, Zwamborn AW, Peeters PH, et al Prediction of peripheral fracture risk by quantitative microdensitometry Prev Med 199726(1):86–91. [PubMed: 9010902]
301.
de Laet CE, van Hout BA, Burger H, et al Bone density and risk of hip fracture in men and women: cross sectional analysis BMJ 1997315(7102):221–5. [PMC free article: PMC2127146] [PubMed: 9253270]
302.
Jones G, Nguyen T, Sambrook P, et al Progressive loss of bone in the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study BMJ 1994309(6956):691–5. [PMC free article: PMC2540818] [PubMed: 7950520]
303.
Masud T, Langley S, Wiltshire P, et al Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis. BMJ. 1993;307:172–3. [PMC free article: PMC1678366] [PubMed: 8343746]
304.
Arlot ME, Sornay-Rendu E, Garnero P, et al Apparent pre- and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: the OFELY cohort J Bone Miner Res 199712(4):683–90. [PubMed: 9101381]
305.
Grampp S, Henk CB, Fuerst TP, et al Diagnostic agreement of quantitative sonography of the calcaneus with dual X-ray absorptiometry of the spine and femur Am J Roentgenol 1999173(2):329–34. [PubMed: 10430129]
306.
Kroger H, Lunt M, Reeve J, et al Bone density reduction in various measurement sites in men and women with osteoporotic fractures of spine and hip: the European quantitation of osteoporosis study Calcif Tissue Int 199964(3):191–9. [PubMed: 10024374]
307.
Varney LF, Parker RA, Vincelette A, et al Classification of osteoporosis and osteopenia in postmenopausal women is dependent on site-specific analysis J Clin Densitomet 19992(3):275–83. [PubMed: 10548823]
308.
Ahmed AIH, Blake GM, Rymer JM, et al Screening for osteopenia and osteoporosis: do the accepted normal ranges lead to overdiagnosis? Osteoporos Int. 1997;7:432–8. [PubMed: 9425500]
309.
Petley GW, Cotton AM, Murrills AJ, et al Reference ranges of bone mineral density for women in southern England: the impact of local data on the diagnosis of osteoporosis Br J Radiol 199669(823):655–60. [PubMed: 8696703]
310.
Chen Z, Maricic M, Lund P, et al How the new Hologic hip normal reference values affect the densitometric diagnosis of osteoporosis. Osteoporos Int. 1998;8:423–7. [PubMed: 9850349]
311.
Simmons A, Barrington S, O'Doherty M, et al Dual energy X-ray absorptiometry normal reference range use within the UK and the effect of different normal ranges on the assessment of bone density Br J Radiol 199568(812):903–9. [PubMed: 7551789]
312.
Lunt M, Felsenberg D, Reeve J, et al Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS Study J Bone Miner Res 199712(11):1883–94. [PubMed: 9383693]
313.
Laskey M, Crisp A, Cole T, et al Comparison of the effect of different reference data on Lunar DPX and Hologic QDR-1000 dual-energy X-ray absorptiometers Br J Radiol 199265(780):1124–9. [PubMed: 1286422]
314.
Kalender WA, Felsenberg D, Genant HK, et al The European Spine Phantom -- a tool for standardization and quality control in spinal bone mineral measurements by DXA and QCT Eur J Radiol 199520(2):83–92. [PubMed: 7588873]
315.
Fischer M, Kempers B Phantom studies in osteoporosis Eur J Nucl Med 199320(5):434–9. [PubMed: 8519262]
316.
Blake GM, Herd RJ, Fogelman I A longitudinal study of supine lateral DXA of the lumbar spine: a comparison with posteroanterior spine, hip and total-body DXA. Osteoporos Int. 1996;6:462–70. [PubMed: 9116392]
317.
Garland SW, Lees B, Stevenson JC DXA longitudinal quality control: a comparison of inbuilt quality assurance, visual inspection, multi-rule Shewhart charts and Cusum analysis Osteoporos Int 19977(3):231–7. [PubMed: 9205636]
318.
Khan KM, Henzell SL, Broderick C, et al Instrument performance in bone density testing at five Australian centres. Aust NZ J Med. 1997;27:526–30. [PubMed: 9404582]
319.
Orwoll ES, Oviatt SK, Biddle JA Precision of dual-energy x-ray absorptiometry: development of quality control rules and their application in longitudinal studies J Bone Miner Res 19938(6):693–9. [PubMed: 8328311]
320.
Pocock NA, Noakes KA, Majerovic Y, et al Magnification error of femoral geometry using fan beam densitometers Calcif Tissue Int 199760(1):8–10. [PubMed: 9030472]
321.
Wahner HW, Looker A, Dunn WL, et al Quality control of bone densitometry in a national health survey (NHANES III) using three mobile examination centers J Bone Miner Res 19949(6):951–60. [PubMed: 8079669]
322.
Kung AW, Tang GW, Luk KD, et al Evaluation of a new calcaneal quantitative ultrasound system and determination of normative ultrasound values in southern Chinese women Osteoporos Int 19999(4):312–7. [PubMed: 10550448]
323.
Fuleihan GE, Testa MA, Angell JE, et al Reproducibility of DXA absorptiometry: a model for bone loss estimates J Bone Miner Res 199510(7):1004–14. [PubMed: 7484275]
324.
Ravaud P, Reny JL, Giraudeau B, et al Individual smallest detectable difference in bone mineral density measurements J Bone Miner Res 199914(8):1449–56. [PubMed: 10457279]
325.
Greenspan SL, Bouxsein ML, Melton ME, et al Precision and discriminatory ability of calcaneal bone assessment technologies J Bone Miner Res 199712(8):1303–13. [PubMed: 9258762]
326.
Kotzki PO, Buyck D, Hans D, et al Influence of fat on ultrasound measurements of the os calcis Calcif Tissue Int 199454(2):91–5. [PubMed: 8012877]
327.
Njeh CF, Boivin CM, Langton CM The role of ultrasound in the assessment of osteoporosis: a review Osteoporos Int 19977(1):7–22. [PubMed: 9102067]
328.
Rico H, Gomez M, Aguado F, et al Impact of weight in obese subjects on bone speed of sound Invest Radiol 199934(9):596–9. [PubMed: 10485076]
329.
Gluer CC, Genant HK Impact of marrow fat on accuracy of quantitative CT J Comput Assist Tomogr 198913(6):1023–35. [PubMed: 2584480]
330.
Howard GM, Nguyen TV, Pocock NA, et al Influence of handedness on calcaneal ultrasound: implications for assessment of osteoporosis and study design Osteoporos Int 19977(3):190–4. [PubMed: 9205629]
331.
Johansen A, Stone MD The effect of ankle oedema on bone ultrasound assessment at the heel Osteoporos Int 19977(1):44–7. [PubMed: 9102062]
332.
Jones G, Nguyen T, Sambrook PN, et al A longitudinal study of the effect of spinal degenerative disease on bone density in the elderly. J Rheumatol. 1995;22:932–6. [PubMed: 8587085]
333.
Agren M, Karellas A, Leahey D, et al Ultrasound attenuation of the calcaneus: a sensitive and specific discriminator of osteopenia in postmenopausal women Calcif Tissue Int 199148(4):240–4. [PubMed: 2059875]
334.
Alenfeld FE, Wuster C, Funck C, et al Ultrasound measurements at the proximal phalanges in healthy women and patients with hip fractures Osteoporos Int 19988(5):393–8. [PubMed: 9850344]
335.
Cunningham J, Fordham J, Hewitt T, et al Ultrasound velocity and attenuation at different skeletal sites compared with bone mineral density measured using dual energy X-ray absorptiometry Br J Radiol 199669(817):25–32. [PubMed: 8785618]
336.
Faulkner KG, McClung MR, Coleman LJ, et al Quantitative ultrasound of the heel: correlation with densitometric measurements at different skeletal sites. Osteoporos Int. 1994;4:42–7. [PubMed: 8148571]
337.
Formica CA, Nieves JW, Cosman F, et al Comparative assessment of bone mineral measurements using dual X-ray absorptiometry and peripheral quantitative computed tomography Osteoporos Int 19988(5):460–7. [PubMed: 9850355]
338.
Graafmans WC, Van Lingen A, Ooms ME, et al Ultrasound measurements in the calcaneus: precision and its relation with bone mineral density of the heel, hip, and lumbar spine Bone 199619(2):97–100. [PubMed: 8853851]
339.
Grampp S, Jergas M, Lang P, et al Quantitative CT assessment of the lumbar spine and radius in patients with osteoporosis Am J Roentgenol 1996167(1):133–40. [PubMed: 8659357]
340.
Laval-Jeantet AM, Bergot C, Williams M, et al Dual-energy X-ray absorptiometry of the calcaneus: comparison with vertebral dual-energy X-ray absorptiometry and quantitative computed tomography Calcif Tissue Int 199556(1):14–8. [PubMed: 7796340]
341.
Martin J, Reid D Appendicular measurements in screening women for low axial bone mineral density Br J Radiol 199669(819):234–40. [PubMed: 8800867]
342.
Massie A, Reid DM, Porter RW Screening for osteoporosis: comparison between dual energy X-ray absorptiometry and broadband ultrasound attenuation in 1000 perimenopausal women Osteoporos Int 19933(2):107–10. [PubMed: 8453190]
343.
Naganathan V, March L, Hunter D, et al Quantitative heel ultrasound as a predictor for osteoporosis Med J Aust 1999171(6):297–300. [PubMed: 10560444]
344.
Pocock NA, Noakes KA, Howard GM, et al Screening for osteoporosis: what is the role of heel ultrasound? Med J Aust. 1996;164:367–70. [PubMed: 8606664]
345.
Rosenthall L, Tenenhouse A, Caminis J A correlative study of ultrasound calcaneal and dual-energy X-ray absorptiometry bone measurements of the lumbar spine and femur in 1000 women Eur J Nucl Med 199522(5):402–6. [PubMed: 7641747]
346.
Roux C, Lemonnier E, Lolta S, et al Broadband ultrasound attenuation of the calcaneus and bone density measurements Rev Rhum Engl Ed 199360(12):771–80.
347.
Salamone L, Krall E, Dawson-Hughes B Comparison of broadband ultrasound attenuation to single X-ray absorptiometry measurements at the calcaneus in postmenopausal women. Calcif Tissue Int. 1994;54:87–90. [PubMed: 8012876]
348.
Schott AM, Weill-Engerer S, Hans D, et al Ultrasound discriminates patients with hip fracture equally well as dual energy X-ray absorptiometry and independently of bone mineral density J Bone Miner Res 199510(2):243–9. [PubMed: 7754803]
349.
Tromp AM, Smit JH, Deeg DJ, et al Quantitative ultrasound measurements of the tibia and calcaneus in comparison with DXA measurements at various skeletal sites Osteoporos Int 19999(3):230–5. [PubMed: 10450412]
350.
Turner C, Peacock M, Timmerman L, et al Calcaneal ultrasonic measurements discriminate hip fracture independently of bone mass. Osteoporos Int. 1995;5:130–5. [PubMed: 7599449]
351.
Young H, Howey S, Purdie DW Broadband ultrasound attenuation compared with dual-energy X-ray absorptiometry in screening for postmenopausal low bone density Osteoporos Int 19933(3):160–4. [PubMed: 8481593]
352.
Salamone LM, Pressman AR, Seeley DG, et al Estrogen replacement therapy. A survey of older women's attitudes. Arch Intern Med. 1996;156:1293–7. [PubMed: 8651837]
353.
Rozenberg S, Kroll M, Vandromme J, et al Effect of bone density evaluation on hormone replacement therapy prescription. Maturitas. 1996;24:57–61. [PubMed: 8794435]
354.
Rimes KA, Salkovskis PM, Shipman AJ Psychological and behavioural effects of bone density screening for osteoporosis. Psychol Health. 1999;14:585–608.
355.
Marci CD, Viechnicki MB, Greenspan SL, et al Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women. Calcif Tissue Int. 2000;66:113–8. [PubMed: 10652958]
356.
Papaioannou A, Parkinson W, Adachi H, et al Women's decisions about hormone replacement therapy after education and bone densitometry Can Med Assoc J 1998159(10):1253–7. [PMC free article: PMC1229820] [PubMed: 9861222]
357.
Silverman SL, Greenwald M, Klein RA, et al Effect of bone density information on decisions about hormone replacement therapy: a randomized trial Obstet Gynecol 199789(3):321–5. [PubMed: 9052578]
358.
Rubin SM, Cummings SR Results of bone densitometry affect women's decisions about taking measures to prevent fractures Ann Intern Med 1992116(12 pt 1):990–5. [PubMed: 1586110]
359.
Stock JL, Waud CE, Coderre JA, et al Clinical reporting to primary care physicians leads to increased use and understanding of bone densitometry and affects the management of osteoporosis: a randomized trial Ann Intern Med 1998128(12):996–9. [PubMed: 9625686]
360.
Nguyen TV, Sambrook PN, Eisman JA Bone loss, physical activity, and weight change in elderly women: the Dubbo Osteoporosis Epidemiology Study J Bone Miner Res 199813(9):1458–67. [PubMed: 9738519]
361.
Cappuccio FP, Meilahn E, Zmuda JM, et al High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group Lancet 1999354(9183):971–5. [PubMed: 10501357]
362.
Burger H, de Laet CE, van Daele PL, et al Risk factors for increased bone loss in an elderly population: the Rotterdam Study Am J Epidemiol 1998147(9):871–9. [PubMed: 9583718]
363.
Wimalawansa SJ A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis. Am J Med. 1998;104:219–26. [PubMed: 9552083]
364.
Braga de Castro Machado A, Hannon R, Eastell R Monitoring alendronate therapy for osteoporosis. J Bone Miner Res. 1999;14:602–8. [PubMed: 10234582]
365.
Faulkner K Bone matters: are density increases necessary to reduce fracture risk? J Bone Miner Res 200015(2):183–7. [PubMed: 10703919]
366.
Hochberg M, Ross P, Black D, et al Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis Arthritis Rheum 199942(6):1246–54. [PubMed: 10366118]
367.
Cummings SR, Palermo L, Browner W, et al Monitoring osteoporosis therapy with bone densitometry. JAMA. 2000;283:1318–21. [PubMed: 10714731]
368.
Calvo M, Eyre D, Gundberg C Molecular basis and clinical application of biological markers of bone turnover Endocr Rev 199617(4):333–68. [PubMed: 8854049]
369.
Garnero P, Delmas PD Biochemical markers of bone turnover. Applications for osteoporosis Endocrinol Metab Clin North Am 199827(2):303–23. [PubMed: 9669140]
370.
Miller PD, Baran DT, Bilezikian JP, et al Practical clinical application of biochemical markers of bone turnover: consensus of an expert panel J Clin Densitomet 19992(3):323–42. [PubMed: 10548827]
371.
Greenspan SL, Dresner-Pollak R, Parker RA, et al Diurnal variation of bone mineral turnover in elderly men and women Calcif Tissue Int 199760(5):419–23. [PubMed: 9115158]
372.
Gertz BJ, Clemens JD, Holland SD, et al Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment Calcif Tissue Int 199863(2):102–6. [PubMed: 9685512]
373.
Uebelhart D, Schlemmer A, Johansen J, et al Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links J Clin Endocrinol Metab 199172(2):367–73. [PubMed: 1991806]
374.
Ravn P, Hosking D, Thompson D, et al Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study J Clin Endocrinol Metab 199984(7):2363–8. [PubMed: 10404804]
375.
Chen JT, Hosoda K, Hasumi K, et al Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women J Bone Miner Res 199611(11):1784–92. [PubMed: 8915787]
376.
Vergnaud P, Garnero P, Meunier PJ, et al Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS study. J Clin Endocrinol Metab. 1997;82:719–24. [PubMed: 9062471]
377.
Gundberg CM, Nieman S D, Abrams S, et al Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin J Clin Endocrinol Metab 199883(9):3258–66. [PubMed: 9745439]
378.
Pansini F, Bonaccorsi G, Calisesi M, et al Evaluation of bone metabolic markers as indicators of osteopenia in climacteric women Gynecol Obstet Invest 199233(4):231–5. [PubMed: 1505813]
379.
Guerrero R, Diaz Martin MA, Diaz Diego EM, et al New biochemical markers of bone resorption derived from collagen breakdown in the study of postmenopausal osteoporosis Osteoporos Int 19966(4):297–302. [PubMed: 8883118]
380.
Melton LJ 3rd, Khosla S, Atkinson EJ, et al Relationship of bone turnover to bone density and fractures J Bone Miner Res 199712(7):1083–91. [PubMed: 9200008]
381.
Minisola S, Pacitti MT, Ombricolo E, et al Bone turnover and its relationship with bone mineral density in pre- and postmenopausal women with or without fractures Maturitas 199829(3):265–70. [PubMed: 9699199]
382.
Taguchi Y, Gorai I, Zhang MG, et al Differences in bone resorption after menopause in Japanese women with normal or low bone mineral density: quantitation of urinary cross-linked N-telopeptides Calcif Tissue Int 199862(5):395–9. [PubMed: 9541516]
383.
Szulc P, Chapuy M, Meunier P, et al Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest. 1993;91:1769–74. [PMC free article: PMC288157] [PubMed: 8473517]
384.
Akesson K, Ljunghall S, Jonsson B, et al Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women J Bone Miner Res 199510(11):1823–9. [PubMed: 8592961]
385.
Ross PD, Kress BC, Parson RE, et al Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporos Int. 2000;11:1176–82. [PubMed: 10663362]
386.
Garnero P, Hausherr E, Chapuy MC, et al Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study J Bone Miner Res 199611(10):1531–8. [PubMed: 8889854]
387.
van Daele PLA, Seibel MJ, Burger H, et al Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study. BMJ. 1996;312:482–3. [PMC free article: PMC2349981] [PubMed: 8597681]
388.
Christiansen C, Riis BJ, Rodbro P Screening procedure for women at risk of developing postmenopausal osteoporosis Osteoporos Int 19901(1):35–40. [PubMed: 2133639]
389.
Nordin BE, Cleghorn DB, Chatterton BE, et al A 5-year longitudinal study of forearm bone mass in 307 postmenopausal women J Bone Miner Res 19938(12):1427–32. [PubMed: 8304042]
390.
Miura H, Yamamoto I, Yuu I, et al Estimation of bone mineral density and bone loss by means of bone metabolic markers in postmenopausal women Endocr J 199542(6):797–802. [PubMed: 8822322]
391.
Reeve J, Pearson J, Mitchell A, et al Evolution of spinal bone loss and biochemical markers of bone remodeling after menopause in normal women Calcif Tissue Int 199557(2):105–10. [PubMed: 7584869]
392.
Rosso R, Minisola S, Scarda A, et al Temporal relationship between bone loss and increased bone turnover: a longitudinal study following natural menopause J Endocrinol Invest 199518(9):723–8. [PubMed: 8719304]
393.
Cosman F, Nieves J, Wilkinson C, et al Bone density change and biochemical indices of skeletal turnover Calcif Tissue Int 199658(4):236–43. [PubMed: 8661954]
394.
Keen RW, Nguyen T, Sobnack R, et al Can biochemical markers predict bone loss at the hip and spine?: a 4-year prospective study of 141 early postmenopausal women Osteoporos Int 19966(5):399–406. [PubMed: 8931035]
395.
Reginster JY, Deroisy R, Collette J, et al Prediction of bone loss rate in healthy postmenopausal women Calcif Tissue Int 199760(3):261–4. [PubMed: 9069163]
396.
Sinigaglia L, Varenna M, Binelli L, et al Serum levels of pyridinium crosslinks in postmenopausal women and in Paget's disease of bone Calcif Tissue Int 199761(4):279–84. [PubMed: 9312197]
397.
Bauer DC Biochemical markers of bone turnover and prediction of hip bone loss in older women: the Study of Osteoporotic Fractures J Bone Miner Res 199914(8):1404–10. [PubMed: 10457273]
398.
Yoshimura N, Hashimoto T, Sakata K, et al Biochemical markers of bone turnover and bone loss at the lumbar spine and femoral neck: the Taiji study Calcif Tissue Int 199965(3):198–202. [PubMed: 10441650]
399.
Garnero P, Sornay-Rendu E, Duboeuf F, et al Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study J Bone Miner Res 199914(9):1614–21. [PubMed: 10469291]
400.
Mariconda M, Pavia M, Colonna A, et al Appendicular bone density, biochemical markers of bone turnover and lifestyle factors in female teachers of Southern Italy Eur J Epidemiol 199713(8):909–17. [PubMed: 9476821]
401.
Hansen MA Assessment of age and risk factors on bone density and bone turnover in healthy premenopausal women Osteoporos Int 19944(3):123–8. [PubMed: 8069050]
402.
Garnero P, Shih WJ, Gineyts E, et al Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment J Clin Endocrinol Metab 199479(6):1693–700. [PubMed: 7989477]
403.
Kyd PA, Vooght KD, Kerkhoff F, et al Clinical usefulness of bone alkaline phosphatase in osteoporosis Ann Clin Biochem 199835(Pt 6):717–25. [PubMed: 9838984]
404.
Garnero P, Darte D, Delmas PD A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover Bone 199924(6):603–9. [PubMed: 10375203]
405.
Ravn P, Clemmesen B, Christiansen C Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women Bone 199924(3):237–44. [PubMed: 10071916]
406.
Overgaard K, Christiansen C A new biochemical marker of bone resorption for follow-up on treatment with nasal salmon calcitonin Calcif Tissue Int 199659(1):12–6. [PubMed: 8661977]
407.
Riis BJ, Overgaard K, Christiansen C Biochemical markers of bone turnover to monitor the bone response to postmenopausal hormone replacement therapy Osteoporos Int 19955(4):276–80. [PubMed: 7492867]
408.
Chesnut CH 3rd, Bell NH, Clark GS, et al Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density Am J Med 1997102(1):29–37. [PubMed: 9209198]
409.
Gonnelli S, Cepollaro C, Pondrelli C, et al The usefulness of bone turnover in predicting the response to transdermal estrogen therapy in postmenopausal osteoporosis J Bone Miner Res 199712(4):624–31. [PubMed: 9101374]
410.
Heikkinen AM, Parviainen M, Niskanen L, et al Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without Vitamin D3: a prospective, controlled, randomized study J Clin Endocrinol Metab 199782(8):2476–82. [PubMed: 9253321]
411.
Rosen CJ, Chesnut CH 3rd, Mallinak NJ The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation J Clin Endocrinol Metab 199782(6):1904–10. [PubMed: 9177404]
412.
Hesley RP, Shepard KA, Jenkins DK, et al Monitoring estrogen replacement therapy and identifying rapid bone losers with an immunoassay for deoxypyridinoline Osteoporos Int 19988(2):159–64. [PubMed: 9666940]
413.
Masahashi T, Negoro Y, Kuroki T, et al Biochemical markers of bone turnover during hormone replacement therapy Int J Gynaecol Obstet 199964(2):163–6. [PubMed: 10189026]
414.
Zhan Z, Yamamoto I, Morita R, et al Urinary pyridinoline and deoxypyridinoline as bone metabolic markers in predicting therapeutic effects of estrogen and alfacalcidol in women with osteoporosis J Bone Miner Metabol 199917(2):113–8. [PubMed: 10340638]
415.
Delmas PD, Hardy P, Garnero P, et al Monitoring individual response to hormone replacement therapy with bone markers Bone 200026(6):553–60. [PubMed: 10831925]
416.
Dresner-Pollak R, Mayer M, Hochner-Celiniker D The decrease in serum bone-specific alkaline phosphatase predicts bone mineral density response to hormone replacement therapy in early postmenopausal women. Calcif Tissue Int. 2000;66:104–7. [PubMed: 10652956]
417.
Bjarnason NH, Christiansen C Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women Bone 200026(6):561–9. [PubMed: 10831926]
418.
Kelepouris N, Harper KD, Gannon F, et al Severe osteoporosis in men Ann Intern Med 1995123(6):452–60. [PubMed: 7639446]
419.
Baillie SP, Davison CE, Johnson FJ, et al Pathogenesis of vertebral crush fractures in men. Age Ageing. 1992;21:139–41. [PubMed: 1575093]
420.
Peris P, Guanabens N, Monegal A, et al Aetiology and presenting symptoms in male osteoporosis. Br J Rheumatol. 1995;34:936–41. [PubMed: 7582699]
421.
Langton CM, Ballard PA, Langton DK, et al Maximizing the cost-effectiveness of BMD referral for DXA using ultrasound as a selective population prescreen Technol Health Care 19975(3):235–41. [PubMed: 9263372]
422.
Langton CM, Langton DK, Beardsworth SA Comparison of accuracy and cost effectiveness of clinical criteria and BUA for referral for BMD assessment by DXA in osteoporotic and osteopenic perimenopausal subjects Technol Health Care 19997(5):319–30. [PubMed: 10543417]
423.
Tosteson A, Rosenthal DI, Melton LJ 3rd., et al Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy Ann Intern Med 1990113(8):594–603. [PubMed: 2119161]
424.
Garton MJ, Cooper C, Reid D Perimenopausal bone density screening -- will it help prevent osteoporosis? Maturitas 199726(1):35–43. [PubMed: 9032745]
425.
Kanis JA, McCloskey EV Evaluation of the risk of hip fracture Bone 199618(3 Suppl):127S–32S. [PubMed: 8777077]
426.
Swedish Council on Technology Assessment in Health Care Bone density measurement-a systematic review J Intern Med 1997241(Suppl 739):1–60. [PubMed: 9104441]
427.
Hailey D, Sampietro-Colom L, Marshall D, et al INAHTA project on the effectiveness of bone density measurement and associated treatments for prevention of fractures. Statement of findings. Edmonton, Alberta, Canada: Alberta Heritage Foundation for Medical Research, on behalf of the International Network of Agencies for Health Technology Assessment; 1996.
428.
Green CJ, Bassett K, Foerster V, et al Bone mineral density testing: does the evidence support its selective use in well women? Vancouver, British Columbia, Canada: British Columbia Office of Health Technology Assessment; 1997. Report No. 97:2T.
429.
Homik J, Hailey D Quantitative ultrasound for bone density measurement. Edmonton, Alberta, Canada: Alberta Heritage Foundation for Medical Research; 1998. Report No. Health Technology Assessment 11.
430.
Homik J, Hailey D Selective testing with bone density measurement. Edmonton, Alberta, Canada: Alberta Heritage Foundation for Medical Research; 1999. Report No. Health Technology Brief 4.
431.
Ultrasonography of the heel for diagnostic osteoporosis and selecting patients for pharmacologic treatment. Chicago: Blue Cross and Blue Shield Association; 1999. [PubMed: 10848085]
432.
Osteoporosis: clinical guidelines for prevention and treatment. London: Royal College of Physicians of London; 1999. [PMC free article: PMC9665447] [PubMed: 11191965]
433.
Consensus statement on prevention and treatment of osteoporosis. 1999. [PubMed: 10892399]
434.
Monitoring of bone density to assess active treatment of osteoporosis. Chicago: Blue Cross and Blue Shield Association; 2000. [PubMed: 10848121]
435.
Bauer DC Personal communication. March 17, 2000.
436.
Health Technology Assessment Number 6: Bone Densitometry: Patients with Asymptomatic Primary Hyperparathyroidism. AHCPR Pub. 1995; 96-0004. [PubMed: 8938232]
437.
Guide to clinical preventive services. 3rd ed. Baltimore: Williams & Wilkins; 1996.
438.
Kreiger N, Kelsey JL, Holford TR, et al An epidemiologic study of hip fracture in postmenopausal women Am J Epidemiol 1982116(1):141–8. [PubMed: 7102649]
439.
Bean N, Bennett KM, Lehmann AB Habitus and hip fracture revisited: skeletal size, strength and cognition rather than thinness? Age Ageing 199524(6):481–4. [PubMed: 8588536]
440.
Turner LW, Wang MQ, Fu Q Risk factors for hip fracture among southern older women South Med J 199891(6):533–40. [PubMed: 9634114]
441.
Smeets-Goevaers CG, Lesusink GL, Papapoulos SE, et al The prevalence of low bone mineral density in Dutch perimenopausal women: the Eindhoven perimenopausal osteoporosis study Osteoporos Int 19988(5):404–9. [PubMed: 9850346]
442.
Kroger H, Tuppurainen M, Honkanen R, et al Bone mineral density and risk factors for osteoporosis -- a population-based study of 1600 perimenopausal women Calcif Tissue Int 199455(1):1–7. [PubMed: 7922782]
443.
Blaauw R, Albertse EC, Beneke T, et al Risk factors for the development of osteoporosis in a South African population. A prospective analysis S Afr Med J 199484(6):328–32. [PubMed: 7740378]
444.
Parra-Cabrera S, Hernandez-Avila M, Tamayo-y-Orozco J, et al Exercise and reproductive factors as predictors of bone density among osteoporotic women in Mexico City Calcif Tissue Int 199659(2):89–94. [PubMed: 8687975]
445.
Shaw CK An epidemiologic study of osteoporosis in Taiwan Ann Epidemiol 19933(3):264–71. [PubMed: 8275199]
446.
Sowers MR, Clark MK, Hollis B, et al Radial bone mineral density in pre- and perimenopausal women: a prospective study of rates and risk factors for loss J Bone Miner Res 19927(6):647–57. [PubMed: 1414483]
447.
Brot C, Jensen LB, Sorensen OH Bone mass and risk factors for bone loss in perimenopausal Danish women J Int Med 1997242(6):505–11. [PubMed: 9437412]
448.
Grampp S, Genant HK, Mathur A, et al Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification J Bone Miner Res 199712(5):697–711. [PubMed: 9144335]
449.
Shiraki M, Kushida K, Fukunaga M, et al A placebo-controlled, single-blind study to determine the appropriate alendronate dosage in postmenopausal Japanese patients with osteoporosis. The Alendronate Research Group Endocr J 199845(2):191–201. [PubMed: 9700472]
450.
Parviainen MT, Jaaskelainen K, Kroger H, et al Urinary bone resorption markers in monitoring treatment of symptomatic osteoporosis Clin Chim Acta 1999279(1-2):145–54. [PubMed: 10064126]
451.
Ravn P, Bidstrup M, Wasnich RD, et al Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trial. Ann Int Med. 1999;131:935–42. [PubMed: 10610644]
452.
Hosking D, Chilvers CED, Christiansen C, et al Prevention of bone loss with alendronate in postmenopausal women under 60 years of age N Engl J Med 1998338(8):485–92. [PubMed: 9443925]
453.
Torgerson DJ, Donaldson C, Reid DM Bone mineral density measurements: are they worth while? J R Soc Med 199689(8):457–61. [PMC free article: PMC1295888] [PubMed: 8795500]
454.
Physician's guide to prevention and treatment of osteoporosis. Washington, DC: Excerpta Medica, Inc.; 1999.
455.
Section III: Guidelines of care on osteoporosis for primary care physicians. 1997:1-7.
456.
AACE clinical practice guidelines for the prevention and treatment of postmenopausal osteoporosis. 1996:1-19. [PubMed: 9160000]
457.
Recommendations for the prevention and treatment of glucocoriticoid-induced osteoporosis. Arthritis Rheum. 1996;39:1791–9. [PubMed: 8912500]
458.
Clinical practice guidelines for the diagnosis and management of osteoporosis. Can Med Assoc J. 1996;155:1113–33. [PMC free article: PMC1335371] [PubMed: 8873639]
459.
Kanis JA, Delmas P, Burckhardt P, et al Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease Osteoporos Int 19977(4):390–406. [PubMed: 9373575]
460.
Summary and recommendations of the report "Osteoporosis -- Clinical guidelines for the prevention and treatment." 1999.
461.
Canadian Consensus Conference on Menopause: Osteoporosis. J Soc Obstet Gynaecol Can; 1998.
462.
The prevention and management of osteoporosis Med J Aust 1997167(Suppl):51–515. [PubMed: 9236768]
463.
Osteoporosis guidelines. San Diego; 1998.
464.
McClung MR Nonpharmacologic management of osteoporosis. In: Marcus R, editor. Osteoporosis. Boston: Blackwell Scientific Publications; 1994. p. 336-53.
465.
Miller PD Management of osteoporosis. Adv Intern Med. 1999;44:175–207. [PubMed: 9929709]
466.
Juby A Managing elderly people's osteoporosis. Why? Who? How? Can Fam Physician. 1999;45:1526–36. [PMC free article: PMC2328450] [PubMed: 10386218]
467.
Rosen CJ The diagnosis and treatment of postmenopausal osteoporosis. In: Rosen CJ, editor. Osteoporosis: diagnostic and therapeutic principles. Totowa, NJ: Humana Press, Inc.; 1996.
468.
Lemcke DP Section IV: Metabolic & Endocrine Disorders, Osteoporosis. In: Lemcke DP, Pattison J, Marshall LA, et al., editors. Primary care of women. Norwalk: Appleton & Lange; 1995.
469.
Slovik DM Section III: Endocrinology, Osteoporosis. In: Carlson KJ, Eisenstat SA, Frigoletto FD, et al., editors. Primary care of women. St. Louis: Mosby; 1995.
470.
Byyny RL, Speroff L, editors A clinical guide for the care of older women. Baltimore: Williams & Wilkins; 1996.
471.
Krane SM, Holick MF Metabolic bone disease. In: Fauci AS, Braunwald E, Isselbacher KJ, et al., editors. Harrison's principles of internal medicine. 14th ed. New York: McGraw-Hill Companies, Inc.; 1998.
472.
Dagago-Jack S, Clutter WE Mineral and metabolic bone disease. In: Ewald GA, McKenzie CR, editors. manual of medical therapeutics. Boston: Little, Brown and Company; 1995.
473.
Reisz LG Osteoporosis. In: Stein JH, editor. Internal medicine. 5th ed. St. Louis: Mosby; 1998.
474.
Andreoli TE, Bennett JC, Carpenter CCJ, et al Cecil essentials of medicine. 4th ed. Philadelphia: WB Saunders Company; 1997.
475.
Neer RM Osteoporosis. In: DeGroot LJ, editor. Endocrinology. Philadelphia: WB Saunders Company; 1995.
476.
Primary osteoporosis In: Wilson JD, Foster DW, Kronenberg HM, et al. Williams textbook of endocrinology. Philadelphia: WB Saunders Company; 1998.
477.
Tohme JF, Cosman F, Lindsay R Osteoporosis. In: Becker KL, editor. Principles and practice of endocrinology and metabolism. Philadelphia: JB Lippincott Company; 1995.
478.
Strewler GJ Mineral metabolism and metabolic bone disease, Chapter 17. In: Greenspan FS, Strewler GJ, editors. Basic and clinical endocrinology. 5th ed. Stamford, CT: Appleton and Lange; 1997.

Views

  • PubReader
  • Print View
  • Cite this Page

Other titles in these collections

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...